NCT02178488View on ClinicalTrials.gov

Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Methicillin Resistant Staphylococcus AureusVitamin D3 Deficiency
Interventions
DRUG

Cholecalciferol

Cholecalciferol 4000 IU/day for 12 months

OTHER

Placebo

Placebo (mimic of cholecalciferol) in the same amount and same time frame as Cholecalciferol for 12 months

Trial Locations (2)

SE_ 141 86

Karolinska University Hospital, Stockholm

SE- 171 76

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Peter Bergman

OTHER

NCT02178488 - Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers | Biotech Hunter | Biotech Hunter